Johnson & Johnson (NYSE:JNJ) has tumbled 1.31% during the past week, however, the bigger picture is still very bullish; the stocks have advanced and posted positive gains of 2.52% in the last four weeks. The stocks have underperformed the S&P 500 by 0.12% during the past week but Johnson & Johnson (NYSE:JNJ) it has outperformed the index in 4 weeks by 1.59%.
Johnson & Johnson (NYSE:JNJ): The stock opened at $116.62 on Friday but the bulls could not build on the opening and the stock topped out at $116.67 for the day. The stock traded down to $115.01 during the day, due to lack of any buying support eventually closed down at $115.48 with a loss of -0.99% for the day. The stock had closed at $116.64 on the previous day. The total traded volume was 10,702,199 shares.
The company shares have rallied 15.64% from its 1 Year high price. On Jun 15, 2016, the shares registered one year high at $117.74 and the one year low was seen on Aug 24, 2015. The 50-Day Moving Average price is $114.12 and the 200 Day Moving Average price is recorded at $107.15.
On the companys insider trading activities, Pruden Gary J, officer (Exec VP, WW Chair, Med Devices) of Johnson & Johnson, unloaded 9,735 shares at an average price of $116.03 on June 7, 2016. The total amount of the transaction was worth $1,129,552, according to the disclosed information with the Securities and Exchange Commission in a Form 4 filing.
Many analysts have stated their opinion on the company shares. Jefferies maintains their rating on the shares of Johnson & Johnson (NYSE:JNJ). The current rating of the shares is Hold. Equity Analysts at the Firm raises the price target to $109 per share from $108 per share. The rating by the firm was issued on June 14, 2016. Currently the company Insiders own 0.11% of Johnson & Johnson shares according to the proxy statements. In the past twelve weeks, the net percent change held by company insiders has changed by -18.24% . Institutional Investors own 67.95% of Johnson & Johnson shares. During last six month period, the net percent change held by insiders has seen a change of -18.24%.
Johnson & Johnson is a holding company. The Company is engaged in the research and development, manufacture and sale of a range of products in the health care field. The Company has more than 265 operating companies conducting business around the world. The Companys primary focus is products related to human health and well-being. The Company is organized into three business segments: Consumer, Pharmaceutical and Medical Devices. The Companys subsidiaries operate 134 manufacturing facilities occupying approximately 21.5 million square feet of floor space. The Companys research facilities are located in the United States, Belgium, Brazil, Canada, China, France, Germany, India, Israel, Japan, the Netherlands, Singapore, Switzerland and the United Kingdom.